Hunter Gillies - Dec 13, 2023 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Signature
/s/ George A. Eldridge, Attorney-in-Fact
Stock symbol
AVTE
Transactions as of
Dec 13, 2023
Transactions value $
-$213,120
Form type
4
Date filed
12/15/2023, 06:00 PM
Previous filing
May 23, 2023
Next filing
Dec 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Options Exercise $3.66K +2.1K +64.69% $1.74 5.35K Dec 13, 2023 Direct F1
transaction AVTE Common Stock Sale -$41K -2.1K -39.28% $19.50 3.25K Dec 13, 2023 Direct F1
transaction AVTE Common Stock Options Exercise $17.2K +9.9K +304.43% $1.74 13.1K Dec 14, 2023 Direct F1
transaction AVTE Common Stock Sale -$193K -9.9K -75.27% $19.50 3.25K Dec 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -653 -4.06% $0.00 15.4K Dec 13, 2023 Common Stock 653 $1.74 Direct F1, F2
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -1.45K -7.65% $0.00 17.5K Dec 13, 2023 Common Stock 1.45K $1.74 Direct F1, F3
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -2.7K -17.48% $0.00 12.7K Dec 14, 2023 Common Stock 2.7K $1.74 Direct F1, F2
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -7.2K -41.12% $0.00 10.3K Dec 14, 2023 Common Stock 7.2K $1.74 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
F2 A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
F3 A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.